Pulmonary Function Abnormalities in Patients with Type 2 Diabetes in Contrast to Healthy Population

Document Type : Original Article

Authors

1 Endocrine Research Center, Mashhad University of Medical Sciences, Mashhad, Iran

2 Lung Diseases Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.

3 Lung Diseases Research Center, Mashhad University of Medical Sciences, Mashhad

4 Department of Internal Medicine, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran

5 Clinical Research Unit, Ghaem Hospital, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad

Abstract

Introduction: Diabetes mellitus is a chronic multisystem disease that lungs are also affected .However, there are conflicting evidence about the abnormal pulmonary function in diabetic patients. This study evaluated the difference between pulmonary function tests among patients with type 2 diabetes and healthy adults.
Material and Methods: This present descriptive cross sectional had been studied in Khorasan Razavi province of Iran from November 2016 to May 2017. The patients with type 2 diabetes which were older than 18 years without history of pulmonary diseases, heart failure, smoking, anemia, musculoskeletal, pulmonary or connective tissue disorders were included in the present study. A group of healthy volunteers participated as a control group with similar age, gender, height and weight to the diabetic participants. Both groups underwent spirometry and body box . Pulmonary function tests among study groups were compared.
Results: Total number of 40 diabetic patients as the case group and 40 healthy individuals as control group enrolled in this study. The control group had significantly higher force vital capacity (FVC), forced expiratory volume in 1 second (FEV1)  and lower FEV1/FVC (P=0.001, P=0.05 and P=0.001 respectively). Males in diabetic groups had significantly lower FVC and FEV1/FVC (P=0.01 and P=0.003) and diabetic females had significantly higher FVC, FEV1 and lower FEV1/FVC (P=0.001, P=0.05 and P=0.003 respectively). According to the linear regression model, by controlling the effect of gender, diabetes significantly affected both FEV1/FVC and FVC levels.
Conclusion: The present study demonstrated that diabetic patients are more likely to develop abnormal pulmonary function and  gender can affect the pulmonary function of the diabetic patients.

Keywords

References

  1. Dall TM, Yang W, Halder P, Pang B, Massoudi M, Wintfeld N, et al. The economic burden of elevated blood glucose levels in 2012: diagnosed and undiagnosed diabetes, gestational diabetes mellitus, and prediabetes. Diabetes care. 2014 Dec 1;37(12):3172-9.
  2. Saeedi P, Petersohn I, Salpea P, Malanda B, Karuranga S, Unwin N, et al . Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas. Diabetes research and clinical practice. 2019 Nov 1;157:107843.
  3. Pitocco D, Fuso L, Conte EG, Zaccardi F, Condoluci C, Scavone G, Incalzi RA, Ghirlanda G. The diabetic lung-a new target organ?. The review of diabetic studies: RDS. 2012;9(1):23.
  4. Khateeb J, Fuchs E, Khamaisi M. Diabetes and lung disease: an underestimated relationship. Review of Diabetic Studies. 2019 Jul 30;15(1):1-5.
  5. Rhee SY, Kim YS. The Role of Advanced Glycation End Products in Diabetic Vascular Complications. Diabetes and Metabolism Journal. 2018;42(3):188-95.
  6. Evcimen ND, King GL. The role of protein kinase C activation and the vascular complications of diabetes. Pharmacological research. 2007 Jun 1;55(6):498-510.
  7. Klein OL, Krishnan JA, Glick S, Smith LJ. Systematic review of the association between lung function and Type 2 diabetes mellitus. Diabetic medicine. 2010 Sep;27(9):977-87.
  8. Hamdy G, Amin M, Rashad A. Pulmonary function changes in diabetic lung. Egyptian Journal of Chest Diseases and Tuberculosis. 2013 Jul 1;62(3):513-7.
  9. Huang H, Guo Q, Li L, Lin S, Lin Y, Gong X, et al. Effect of type 2 diabetes mellitus on pulmonary function. Experimental and Clinical Endocrinology & Diabetes. 2014 Jun;122(06):322-6.
  10. Aparna A. Pulmonary function tests in type 2 diabetics and non-diabetic people-a comparative study. Journal of Clinical & Diagnostic Research. 2013 Aug 1;7(8).
  11. Kwon CH, Rhee EJ, Song JU, Kim JT, Kwag HJ, Sung KC. Reduced lung function is independently associated with increased risk of type 2 diabetes in Korean men. Cardiovascular Diabetology. 2012 Dec;11(1):1-8.
  12. Anandhalakshmi S, Manikandan S, Ganeshkumar P, Ramachandran C. Alveolar gas exchange and pulmonary functions in patients with type II diabetes mellitus. Journal of Clinical and Diagnostic Research: JCDR. 2013 Sep;7(9):1874.
  13. Uz-Zaman S, Banerjee J, Singhamahapatra A, Dey PK, Roy A, Roy K, et al. Assessment of lung function by spirometry and diffusion study and effect of glycemic control on pulmonary function in type 2 diabetes mellitus patients of the eastern India. Journal of Clinical and Diagnostic Research: JCDR. 2014 Nov;8(11):BC01.
  14. Engström G, Hedblad B, Nilsson P, Wollmer P, Berglund G, Janzon L. Lung function, insulin resistance and incidence of cardiovascular disease: a longitudinal cohort study. Journal of internal medicine. 2003 May;253(5):574-81.
  15. Ford ES, Mannino DM. Prospective association between lung function and the incidence of diabetes: findings from the National Health and Nutrition Examination Survey Epidemiologic Follow-up Study. Diabetes Care. 2004 Dec 1;27(12):2966-70.
  16. Yeh HC, Punjabi NM, Wang NY, Pankow JS, Duncan BB, Brancati FL. Vital capacity as a predictor of incident type 2 diabetes: the Atherosclerosis Risk in Communities study. Diabetes care. 2005 Jun 1;28(6):1472-9.
  17. Yeh F, Dixon AE, Marion S, Schaefer C, Zhang Y, Best LG, et al. Obesity in adults is associated with reduced lung function in metabolic syndrome and diabetes: the Strong Heart Study. Diabetes care. 2011 Oct 1;34(10):2306-13.
  18. Leone N, Courbon D, Thomas F, Bean K, Jégo B, Leynaert B, et al. Lung function impairment and metabolic syndrome: the critical role of abdominal obesity. American journal of respiratory and critical care medicine. 2009 Mar 15;179(6):509-16.
  19. Mishra T, Dube S, Dave L, Dubey TN. Case Control Study on Pulmonary Function in People with Type 2 Diabetes Mellitus.
  20. Chance WW, Rhee C, Yilmaz C, Dane DM, Pruneda ML, Raskin P, et al. Diminished alveolar microvascular reserves in type 2 diabetes reflect systemic microangiopathy. Diabetes care. 2008 Aug 1;31(8):1596-601.
  21. Ramirez LC, Dal Nogare A, Hsia C, Arauz C, Butt I, Strowig SM, et al. Relationship between diabetes control and pulmonary function in insulin-dependent diabetes mellitus. The American journal of medicine. 1991 Oct 1;91(4):371-6.
  22. Weir DC, Jennings PE, Hendy MS, Barnett AH, Burge PS. Transfer factor for carbon monoxide in patients with diabetes with and without microangiopathy. Thorax. 1988 Sep;43(9):725.
Journal of Cardio-Thoracic Medicine
Volume 10, Issue 2
June 2022
Pages 974-980

Files

Share

How to cite

Statistics